Thromboprophylaxis; what is the future, for high risk surgical patients?

Phlebology. 2022 Mar;37(2):81-83. doi: 10.1177/02683555211031326. Epub 2021 Jul 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants* / therapeutic use
  • Heparin, Low-Molecular-Weight / adverse effects
  • Humans
  • Postoperative Complications / prevention & control
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight